Filtering by content type: Case
The Federal Trade Commission has filed an administrative complaint alleging that Altria Group, Inc. and JUUL Labs, Inc. entered a series of agreements, including Altria’s acquisition of a 35% stake in JUUL, that eliminated competition in violation of federal antitrust laws. According...
Filtering by content type: Press Release
Today, the Federal Trade Commission filed an administrative complaint alleging that Altria Group, Inc. and JUUL Labs, Inc. entered a series of agreements, including Altria’s acquisition of a 35% stake in JUUL, that eliminated competition in violation of federal antitrust laws.
The Federal Trade Commission will host a public workshop on September 22, 2020, to examine the potential benefits and challenges to consumers and competition raised by data portability.
The Federal Trade Commission, in partnership with the Department of Justice’s Antitrust Division, will resume the practice of granting early termination of the HSR Act’s waiting periods when both agencies have determined that no enforcement action will be taken during the waiting period, the agency...
The Federal Trade Commission and the U.S. Department of Justice Antitrust Division today issued joint statement detailing an expedited antitrust procedure and providing guidance for collaborations of businesses working to protect the health and safety of Americans during the COVID-19 pandemic.
The staff of Federal Trade Commission’s Office of Policy Planning, Bureau of Economics, and Bureau of Competition, together with the staff of the Antitrust Division of the Department of Justice, have submitted a letter to California State Assembly Member Jim Wood raising concerns that California...
Danaher Corporation has agreed to divest assets to settle Federal Trade Commission charges that its proposed $21.4 billion acquisition of General Electric’s biopharmaceutical business, GE Biopharma, would violate federal antitrust law.
Filtering by content type: Blog Post
On Friday, March 13, as part of the Bureau’s response to the COVID-19 coronavirus situation, and in partnership with the Antitrust Division of DOJ, we announced that the Bureau’s Premerger Notification Office would adopt a
Filtering by content type: Public Statement
Filtering by content type: Federal Register Notice
Filtering by content type: Advocacy Filing
Comment by FTC and DOJ staff in response to invitation from California Assembly Member Jim Wood concerning the likely competitive effects of A.B.1541, a proposal to further restrict contracting between beer manufacturers and beer wholesalers.
Filtering by content type: Advisory Opinion
Manufacturing of polypropylene using propylene as a feedstock constitutes "petrochemical processing" and is an "oil and gas related asset" within the meaning of the Consent Order issued against respondent, Decisions Volume 104
Proposed development of a relative value guide for physician services to be distributed to member internists would be likely to have anticompetitive effects that probably would not be outweighed by any counterveiling efficiency justifications, Decisions Volume 105
Proposed barter program with foreign countries for phosphate rock would avoid respondent's involvement in other than export trade and falls under the protection of the Webb-Pomerene Act, Decisions Volume 108
Proposed acquisition by Coca-Cola would require prior Commission approval under the Commission's order of August 3, 1983, Decisions Volume 111
The proposed Code of Conduct of the Association of Trial Lawyers of America does not appear likely to have a significant anticompetitive effect and therefore, to violate Section 5 of the FTC Act, Decisions Volume 114
Re: The application of the Non-Profit Institutions Act to sales of pharmaceuticals by non-profit hospitals to related non-profit long-term care facilities, Decisions Volume 116
Re: A program proposed by the American Medical Association and the Chicago Medical Society involving peer review of physician fees is not likely to violate antitrust laws, Decisions Volume 117